Efficacy and Safety of Substitution of Glucocorticoid for BDB-001 Injection in Patients With Anti-neutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

February 22, 2022

Primary Completion Date

March 19, 2025

Study Completion Date

March 19, 2025

Conditions
ANCA-associated Vasculitis
Interventions
DRUG

BDB-001 injection

Intravenously administered

DRUG

Cyclophosphamide

Intravenously administered

DRUG

Glucocorticoids

Orally administered

Trial Locations (22)

100005

Peking Union Medical College Hospital, Beijing

Tongji Hospital,Tongji Medical college of Hust, Wuhan

100034

Peking University First Hospital, Beijing

102206

Peking University International Hospital, Beijing

110001

The First Hospital of China Medical University, Shenyang

110004

Shengjing Hospital of China Medical University, Shengyang

200032

Zhongshan hospital,Fudan University, Shanghai

230601

The Second hospital Of Anhui Medical University, Hefei

300052

Tianjin Medical University General Hospital, Tianjin

310003

The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou

330006

The First Affiliated Hospital of Nanchang University, Nanchang

410008

Xiangya Hospital Central South University (Nephrology Department), Changsha

Xiangya Hospital Central South University(Rheumatism Immunity Branch), Changsha

410205

The Third Xiangya Hospital of Central South University, Changsha

450052

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

471003

The First Affiliated Hospital of Henan University of science and Technology, Luoyang

530016

Guangxi Academy of Medical Sciences,The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning

710032

Xijing Hospital, Xi’an

710061

The First Affiliated Hospital of Xi'an Jiao Tong University, Xi’an

750003

General Hospital of Ningxia Medical University, Yinchuan

050004

The Second hospital of Hebei Medical University, Shijiazhuang

050051

The Third hospital of Hebei Medical University, Shijiazhuang

All Listed Sponsors
lead

Staidson (Beijing) Biopharmaceuticals Co., Ltd

INDUSTRY